126 related articles for article (PubMed ID: 11886970)
1. Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients.
Rau R; Herborn G; Menninger H; Sangha O
Rheumatology (Oxford); 2002 Feb; 41(2):196-204. PubMed ID: 11886970
[TBL] [Abstract][Full Text] [Related]
2. Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate.
Rau R; Herborn G; Menninger H; Sangha O
Br J Rheumatol; 1998 Nov; 37(11):1220-6. PubMed ID: 9851273
[TBL] [Abstract][Full Text] [Related]
3. A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis.
Menninger H; Herborn G; Sander O; Blechschmidt J; Rau R
Br J Rheumatol; 1998 Oct; 37(10):1060-8. PubMed ID: 9825744
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients.
Rau R; Herborn G; Menninger H; Blechschmidt J
Br J Rheumatol; 1997 Mar; 36(3):345-52. PubMed ID: 9133967
[TBL] [Abstract][Full Text] [Related]
5. A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis.
Rau R; Herborn G; Karger T; Menninger H; Elhardt D; Schmitt J
J Rheumatol; 1991 Mar; 18(3):328-33. PubMed ID: 1906935
[TBL] [Abstract][Full Text] [Related]
6. Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis--a randomized, double blind 26-week trial.
Morassut P; Goldstein R; Cyr M; Karsh J; McKendry RJ
J Rheumatol; 1989 Mar; 16(3):302-6. PubMed ID: 2498513
[TBL] [Abstract][Full Text] [Related]
7. The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years.
Rau R; Herborn G; Zueger S; Fenner H
J Rheumatol; 2000 Nov; 27(11):2566-75. PubMed ID: 11093435
[TBL] [Abstract][Full Text] [Related]
8. Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis--preliminary results of a multicenter, randomized, parallel, double blind study.
Rau R; Wassenberg S; Zeidler H;
Z Rheumatol; 2000; 59 Suppl 2():II/90-6. PubMed ID: 11155812
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of parenteral methotrexate and parenteral gold in the treatment of early erosive rheumatoid arthritis: an interim report on 102 patients after 12 months.
Rau R; Herborn G; Karger T; Menninger H; Elhardt D; Schmitt J
Semin Arthritis Rheum; 1991 Oct; 21(2 Suppl 1):13-20. PubMed ID: 1749945
[TBL] [Abstract][Full Text] [Related]
10. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
van der Heijde D; Klareskog L; Rodriguez-Valverde V; Codreanu C; Bolosiu H; Melo-Gomes J; Tornero-Molina J; Wajdula J; Pedersen R; Fatenejad S;
Arthritis Rheum; 2006 Apr; 54(4):1063-74. PubMed ID: 16572441
[TBL] [Abstract][Full Text] [Related]
11. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW;
Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128
[TBL] [Abstract][Full Text] [Related]
12. [Data of two years of the comparative study methotrexate/aurothiomalate in 102 patients].
Herborn G; Rau R; Menninger H; Elhardt D; Schmitt J
Z Rheumatol; 1992; 51(4):163-71. PubMed ID: 1414040
[TBL] [Abstract][Full Text] [Related]
13. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
Genovese MC; Bathon JM; Martin RW; Fleischmann RM; Tesser JR; Schiff MH; Keystone EC; Wasko MC; Moreland LW; Weaver AL; Markenson J; Cannon GW; Spencer-Green G; Finck BK
Arthritis Rheum; 2002 Jun; 46(6):1443-50. PubMed ID: 12115173
[TBL] [Abstract][Full Text] [Related]
14. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
15. Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate.
Sander O; Herborn G; Bock E; Rau R
Ann Rheum Dis; 1999 May; 58(5):281-7. PubMed ID: 10225812
[TBL] [Abstract][Full Text] [Related]
16. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
[TBL] [Abstract][Full Text] [Related]
17. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.
Maini RN; Breedveld FC; Kalden JR; Smolen JS; Furst D; Weisman MH; St Clair EW; Keenan GF; van der Heijde D; Marsters PA; Lipsky PE;
Arthritis Rheum; 2004 Apr; 50(4):1051-65. PubMed ID: 15077287
[TBL] [Abstract][Full Text] [Related]
18. Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE).
Smolen JS; Wollenhaupt J; Gomez-Reino JJ; Grassi W; Gaillez C; Poncet C; Le Bars M; Westhovens R
Arthritis Res Ther; 2015 Jun; 17(1):157. PubMed ID: 26063454
[TBL] [Abstract][Full Text] [Related]
19. Combination DMARD treatment with parenteral gold and methotrexate.
Rau R
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S83-90. PubMed ID: 10589364
[TBL] [Abstract][Full Text] [Related]
20. Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA).
Hørslev-Petersen K; Hetland ML; Ørnbjerg LM; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
Ann Rheum Dis; 2016 Sep; 75(9):1645-53. PubMed ID: 26489704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
